Compliance, Containment, Cosmetics and Life Science

FDA Warns About Compounded Versions of Ozempic and Wegovy

XTalks

JUNE 5, 2023

Ozempic and Wegovy, which contain the active ingredient semaglutide, were approved by the US Food and Drug Administration (FDA). During a drug shortage, compounders might be allowed to prepare a compounded version of the drug provided they meet specific requirements of the Federal Food, Drug, and Cosmetic (FD&C) Act.

FDA Approval

FDA Approval Containment Drugs Pharmacy

Florida approved to import Canadian prescription drugs

Pharma in Brief

JANUARY 7, 2024

Section 804 Importation Programs On October 1, 2020, the FDA published a rule entitled Importation of Prescription Drugs (the US Importation Rule ) to implement Section 804 of the Food, Drug, and Cosmetic Act.

Drugs

Drugs Regulation FDA Approval Manufacturing

Clinical Research Informer

FDA Warns About Compounded Versions of Ozempic and Wegovy

Florida approved to import Canadian prescription drugs

Stay Connected